Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma

To optimize specimen adequacy, our institution standardized technical 1st pull bone marrow aspirates (BMA) for minimal residual disease (MRD) testing in multiple myeloma. We are reporting assay performance characteristics from 556 MRD tests performed by flow cytometry. Ten million assay input was re...

Descripción completa

Detalles Bibliográficos
Autores principales: Foureau, David M., Paul, Barry A., Guo, Fei, Lipford, Edward H., Fesenkova, Kateryna, Tjaden, Elise, Drummond, Kendra, Bhutani, Manisha, Atrash, Shebli, Ndiaye, Ami, Varga, Cindy, Voorhees, Peter M., Usmani, Saad Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448729/
https://www.ncbi.nlm.nih.gov/pubmed/36443182
http://dx.doi.org/10.1016/j.clml.2022.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448729/
https://www.ncbi.nlm.nih.gov/pubmed/36443182
http://dx.doi.org/10.1016/j.clml.2022.10.008

Ejemplares similares